Lotiglipron
A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese
Pfizer · Phase 1 · Completed · Enrollment 20
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Formulation A (Reference) followed by Formulation B (Test) | n/r | n/r | n/r | n/r |
| Formulation B (Test) followed by Formulation A (Reference) | n/r | n/r | n/r | n/r |
Not shown
- Formulation A (Reference) followed by Formulation B (Test): endpoint not reported
- Formulation B (Test) followed by Formulation A (Reference): endpoint not reported